Striatal Dopamine Transporter Alterations in ADHD: Pathophysiology or Adaptation to Psychostimulants? A Meta-Analysis
about
Why most biomedical findings echoed by newspapers turn out to be false: the case of attention deficit hyperactivity disorderNeuroanatomic and cognitive abnormalities in attention-deficit/hyperactivity disorder in the era of 'high definition' neuroimagingPharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.Biomarkers in the diagnosis of ADHD--promising directionsNeuroimaging of attention-deficit/hyperactivity disorder: current neuroscience-informed perspectives for cliniciansMissense dopamine transporter mutations associate with adult parkinsonism and ADHD.Effects of stimulants on brain function in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.Imaging the ADHD brain: disorder-specificity, medication effects and clinical translation.Multimodal MR imaging of brain iron in attention deficit hyperactivity disorder: a noninvasive biomarker that responds to psychostimulant treatment?Real-time fMRI neurofeedback in adolescents with attention deficit hyperactivity disorder.The effects of methylphenidate on cerebral activations to salient stimuli in healthy adults.Cardiovascular safety of stimulants in children with attention-deficit/hyperactivity disorder: a nationwide prospective cohort study.Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.Operationalizing Cognitive Science and Technologies' Research and Development; the "Brain and Cognition Study Group (BCSG)" Initiative from Shiraz, Iran.Reduced dopamine transporter functioning induces high-reward risk-preference consistent with bipolar disorderConnectivity supporting attention in children with attention deficit hyperactivity disorderThe catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.Attention-deficit/hyperactivity disorder in relation to addictive behaviors: a moderated-mediation analysis of personality-risk factors and sex.Dopamine in socioecological and evolutionary perspectives: implications for psychiatric disorders.Effect of olfactory manganese exposure on anxiety-related behavior in a mouse model of iron overload hemochromatosis.Diagnosis and characterization of mania: Quantifying increased energy and activity in the human behavioral pattern monitorFunctional genomics of attention-deficit/hyperactivity disorder (ADHD) risk alleles on dopamine transporter binding in ADHD and healthy control subjectsAdolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood.Working memory capacity predicts effects of methylphenidate on reversal learningOsmotic release oral system-methylphenidate improves neural activity during low reward processing in children and adolescents with attention-deficit/hyperactivity disorder.Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys.A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD).Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology.A short review on the relation between the dopamine transporter 10/10-repeat allele and ADHD: implications for HIV infection.Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents.Prefrontal cortical α2A-adrenoceptors and a possible primate model of attention deficit and hyperactivity disorder.Network Structure among Brain Systems in Adult ADHD is Uniquely Modified by Stimulant Administration.Stimulant-induced psychosis: importance of patient education and compliance.Availability of Striatal Dopamine Transporter in Healthy Individuals With and Without a Family History of ADHD.Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment.Adolescent atomoxetine treatment in a rodent model of ADHD: effects on cocaine self-administration and dopamine transporters in frontostriatal regions.Striatal presynaptic dopamine in schizophrenia, Part I: meta-analysis of dopamine active transporter (DAT) density.Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD.No genetic association between attention-deficit/hyperactivity disorder (ADHD) and Parkinson's disease in nine ADHD candidate SNPs.
P2860
Q24288708-7A916237-742D-4E18-AAD1-D520251A9273Q26859175-61BB18BD-8EFE-4031-958D-2DD0006B403BQ27687469-A47C1D10-DAB5-418F-84AA-810724D80554Q28085253-460F1C32-E93A-4BE3-99F9-5DC67E62FB61Q28249420-CFCCAEF9-59FC-4B71-9D4B-CD84548ECF44Q28272246-B09C0F9F-812A-4328-8C79-CB551291E8E3Q30581669-6025D7F4-02F1-483C-A40B-BAC1021E1B0DQ30710211-BD40CE55-AF79-4735-8083-DE5B27FF12EFQ30802491-09974828-9A97-4008-9167-28BE5C1A968DQ30831762-90CF99DA-033E-4A57-88EE-21B95F454CECQ33697918-F360E659-7BD8-4DCA-8882-91738C7C65E0Q33929815-FF95F0FE-311C-48F7-BB5F-C4CDEDB69E9EQ34063584-58DC3BFF-15F8-4385-AF6A-650EE1328391Q34257043-B59CE310-5B24-4C09-BA92-34A2FF59C63CQ34368128-783AA13E-AFDC-41E5-BD29-72853BE15A96Q34499376-63D41E05-E2BA-4E35-836D-00BA3F05B277Q34988417-891A0707-0127-4AB0-87E1-20F6708BD59BQ35054681-40717A16-785D-49A7-AB1C-40FE322587ECQ35486676-47A78529-1A77-479B-AFBB-D36B6AC17A85Q35746544-9AA4D5FF-1E8B-46CF-93D2-9C17560F0B19Q35908873-63C947CB-F385-47CA-9410-2969301061C0Q36948390-4AB1D240-5E75-47EF-8165-7A8000CC0405Q36980022-5D342F0F-8A90-406F-AE1D-B2B0B2ABC926Q37005445-851B37F3-6CF4-4A4C-9B5C-68982F79498BQ37103313-A4B31BDC-E151-45B4-A62B-BC62D34D2634Q37184589-B245093C-482D-40E0-A4E7-BCDC3D11BEE4Q37390217-FB20A6EA-D77D-45DB-9F5D-3E72FF04E0F4Q38164670-2C28A447-FCC0-4C34-8AFA-B7B19B1B31CEQ38187892-8D62ACA6-777A-427E-8B82-CA2B285260C7Q38201661-C23820AA-AA1F-4F98-96E0-84DAED0774F6Q38387691-9715F9CD-C0D9-4C0B-8A86-702D02E8BA55Q38395722-F4A4FCD1-4051-4A68-8E7D-7733B169AB05Q38406698-B682FA3A-CFCE-4D76-AA9C-3B37DFCB705DQ38634474-2F318CA7-D96E-4EC2-AEDD-81E631C94ACEQ39613122-63A77336-7681-4FCE-9E0E-3894AC1C3EF0Q39735203-3B048CE2-A6E7-4229-B80C-BDCB5D8B302BQ42007774-94133704-9792-4D72-80E6-DD4AFC1C98A9Q42413756-B7FCD171-F80F-49E9-8936-9EDE8E39DDCBQ44596771-8A21DD61-FABF-4167-AC89-13C0FCBB8725Q47805564-366DFB01-9118-4617-B0E3-A90071F534E7
P2860
Striatal Dopamine Transporter Alterations in ADHD: Pathophysiology or Adaptation to Psychostimulants? A Meta-Analysis
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Striatal Dopamine Transporter ...... chostimulants? A Meta-Analysis
@ast
Striatal Dopamine Transporter ...... chostimulants? A Meta-Analysis
@en
Striatal Dopamine Transporter ...... chostimulants? A Meta-Analysis
@en-gb
Striatal Dopamine Transporter ...... chostimulants? A Meta-Analysis
@nl
type
label
Striatal Dopamine Transporter ...... chostimulants? A Meta-Analysis
@ast
Striatal Dopamine Transporter ...... chostimulants? A Meta-Analysis
@en
Striatal Dopamine Transporter ...... chostimulants? A Meta-Analysis
@en-gb
Striatal Dopamine Transporter ...... chostimulants? A Meta-Analysis
@nl
altLabel
Striatal dopamine transporter ...... chostimulants? A meta-analysis
@en
prefLabel
Striatal Dopamine Transporter ...... chostimulants? A Meta-Analysis
@ast
Striatal Dopamine Transporter ...... chostimulants? A Meta-Analysis
@en
Striatal Dopamine Transporter ...... chostimulants? A Meta-Analysis
@en-gb
Striatal Dopamine Transporter ...... chostimulants? A Meta-Analysis
@nl
P50
P921
P3181
P1476
Striatal Dopamine Transporter ...... chostimulants? A Meta-Analysis
@en
P2093
Giorgio Rossi
P304
P3181
P356
10.1176/APPI.AJP.2011.11060940
P407
P577
2012-03-01T00:00:00Z